Publicaciones en colaboración con investigadores/as de Hospital de Cruces (18)

2024

  1. Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease

    npj Parkinson's Disease, Vol. 10, Núm. 1

2022

  1. Potential Tear Biomarkers for the Diagnosis of Parkinson’s Disease—A Pilot Study

    Proteomes, Vol. 10, Núm. 1

2021

  1. Recommendations for ophthalmologic practice during the easing of COVID-19 control measures

    Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983

2020

  1. Changes in the corneal thickness and limbus after 1 year of scleral contact lens use

    Eye (Basingstoke), Vol. 34, Núm. 9, pp. 1654-1661

2018

  1. Dexamethasone protects retinal ganglion cells but not Müller glia against hyperglycemia in vitro

    PLoS ONE, Vol. 13, Núm. 11

  2. Efficacy and safety of an aflibercept treat-and-extend regimen in treatment-naïve patients with macular oedema secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial

    Journal of Ophthalmology, Vol. 2018

2017

  1. Effect of hypoxia on the retina and superior colliculus of neonatal pigs

    PLoS ONE, Vol. 12, Núm. 4

2014

  1. Human tear peptide/protein profiling study of ocular surface diseases by SPE-MALDI-TOF mass spectrometry analyses

    EuPA Open Proteomics, Vol. 3, pp. 206-215

2013

  1. Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat

    Experimental Eye Research, Vol. 110, pp. 55-58

  2. Novel molecular diagnostic system of limbal stem cell deficiency based on MUC5AC transcript detection in corneal epithelium by PCR-reverse dot blot

    Investigative Ophthalmology and Visual Science, Vol. 54, Núm. 8, pp. 5643-5652

  3. Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction

    Journal of Proteomics, Vol. 78, pp. 94-112

2012

  1. Comparative study of limbal stem cell deficiency diagnosis methods: Detection of MUC5AC mRNA and goblet cells in corneal epithelium

    Ophthalmology, Vol. 119, Núm. 5, pp. 923-929

  2. Effect of synthetic cannabinoid CB1 agonist (WIN 55212-2) and antagonist (AM 251) on intraocular pressure in rats

    Glaucoma: Etiology, Pathogenesis and Treatments (Nova Science Publishers, Inc.), pp. 147-156

  3. In vitro effects of three blood derivatives on human corneal epithelial cells

    Investigative Ophthalmology and Visual Science, Vol. 53, Núm. 9, pp. 5571-5578

2011

  1. Current trends in glaucoma: What's about neuroprotection?

    Advances in Medicine and Biology (Nova Science Publishers, Inc.), pp. 149-174

  2. Prevention of retinal ganglion cell swelling by systemic brimonidine in a rat experimental glaucoma model

    Clinical and Experimental Ophthalmology, Vol. 39, Núm. 8, pp. 799-807

2010

  1. Optic neuropathy in methylmalonic acidemia: The role of neuroprotection

    Journal of Inherited Metabolic Disease, Vol. 33, Núm. SUPPL. 3

  2. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects

    Cornea, Vol. 29, Núm. 8, pp. 843-848